Stralem & Co’s Cigna CI Stock Holding History

Stralem & Co’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$6K	Hold	34	–	–	﹤0.01%	68
2020 Q1	$6K	Buy	+34	New	+$6.6K	﹤0.01%	65

Other funds holding CI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Stralem & Co's CI Position: Q2 2020 in Review

Stralem & Co held its Cigna (CI) position steady in Q2 2020 at 34 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #68.

Stralem & Co first reported a position in CI in Q1 2020 and has held it in 2 quarters since. 1,163 funds tracked by Wall St. Rank hold CI as of Q2 2020.

Stralem & Co held 34 shares of Cigna worth $6K as of Q2 2020.
Stralem & Co left its Cigna share count unchanged in Q2 2020.
Cigna made up ﹤0.01% of Stralem & Co's portfolio in Q2 2020, its #68 holding.
Stralem & Co first reported a position in Cigna in Q1 2020 and has held it in 2 quarters since.
1,163 funds tracked by Wall St. Rank held Cigna as of Q2 2020.

Based on Stralem & Co's 13F filing for Q2 2020, filed 20 Jul 2020.